Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation.
We have investigated the effect of nitric oxide (NO) on apoptosis in Swiss 3T3 fibroblasts and compared it to the effect of the nitrosonium cation (NO+). Both species induced apoptosis, confirmed by electron microscopy, propidium iodide staining, DNA laddering and activation of caspases. The kinetics of triggering apoptosis were different for the two redox species: NO+ required only a 2 hour exposure, whereas NO required 24 hours. Three sources of NO were used: aqueous solutions of NO and two NO donors, S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine. The time course of apoptosis induced by these two S-nitrosothiols correlated with their rate of decomposition to NO. The apoptotic effect of NO was reduced in the presence of the NO scavenger oxyhaemoglobin, or the antioxidants N-acetylcysteine and ascorbic acid, whereas in the case of NO+ these antioxidants potentiated apoptosis. Glutathione also had a potentiating effect on the cytotoxicity of NO+. This suggests that cellular antioxidants may play a role in protecting the cell from NO-induced apoptosis while NO+ may trigger apoptosis independently of oxidative stress mechanisms.
Khan
S
S
Department of Chemistry, King's College London, Strand, London WC2R 2LS, UK.
Kayahara
M
M
Joashi
U
U
Mazarakis
N D
ND
Sarraf
C
C
Edwards
A D
AD
Hughes
M N
MN
Mehmet
H
H
D016475:3T3 Cells / Q000166:cytology* / Q000378:metabolism / Q000648:ultrastructure; D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D000931:Antidotes / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001205:Ascorbic Acid / Q000494:pharmacology; D002352:Carrier Proteins / Q000494:pharmacology; D002412:Cations / Q000378:metabolism*; D053938:DNA Fragmentation; D004305:Dose-Response Relationship, Drug; D016166:Free Radical Scavengers / Q000494:pharmacology; D005978:Glutathione / Q000031:analogs & derivatives / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008565:Membrane Proteins / Q000494:pharmacology; D051379:Mice; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D008928:Mitochondria / Q000737:chemistry / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism* / Q000494:pharmacology; D009603:Nitroso Compounds / Q000494:pharmacology; D010108:Oxyhemoglobins / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D026422:S-Nitrosoglutathione; D052067:Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins; D013997:Time Factors; D033921:Vesicular Transport Proteins
D000931:Antidotes; D000975:Antioxidants; D002352:Carrier Proteins; D002412:Cations; D016166:Free Radical Scavengers; D008565:Membrane Proteins; D009603:Nitroso Compounds; D010108:Oxyhemoglobins; D010975:Platelet Aggregation Inhibitors; D052067:Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins; D033921:Vesicular Transport Proteins; D009569:Nitric Oxide; D026422:S-Nitrosoglutathione; D011065:Poly(ADP-ribose) Polymerases; D005978:Glutathione; D001205:Ascorbic Acid; D000111:Acetylcysteine